Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$12.55 - $17.22 $14,570 - $19,992
-1,161 Reduced 18.09%
5,258 $88,000
Q4 2023

Feb 12, 2024

SELL
$9.64 - $14.59 $136,675 - $206,857
-14,178 Reduced 68.84%
6,419 $90,000
Q3 2023

Nov 13, 2023

BUY
$10.3 - $15.99 $9,857 - $15,302
957 Added 4.87%
20,597 $212,000
Q2 2023

Aug 10, 2023

BUY
$8.48 - $16.48 $20,682 - $40,194
2,439 Added 14.18%
19,640 $323,000
Q1 2023

May 12, 2023

SELL
$6.41 - $9.95 $3,846 - $5,970
-600 Reduced 3.37%
17,201 $157,000
Q4 2022

Feb 10, 2023

BUY
$5.02 - $10.0 $8,534 - $17,000
1,700 Added 10.56%
17,801 $127,000
Q3 2022

Nov 14, 2022

BUY
$2.57 - $7.31 $35,915 - $102,157
13,975 Added 657.34%
16,101 $81,000
Q1 2022

May 04, 2022

SELL
$5.46 - $8.29 $218 - $331
-40 Reduced 1.85%
2,126 $15,000
Q3 2021

Nov 05, 2021

SELL
$6.49 - $9.91 $52,225 - $79,745
-8,047 Reduced 78.79%
2,166 $21,000
Q2 2021

Aug 02, 2021

SELL
$6.73 - $9.05 $6,730 - $9,050
-1,000 Reduced 8.92%
10,213 $69,000
Q4 2020

Feb 10, 2021

SELL
$5.03 - $7.95 $23,832 - $37,667
-4,738 Reduced 29.7%
11,213 $75,000
Q3 2020

Nov 12, 2020

BUY
$5.02 - $8.98 $49,954 - $89,359
9,951 Added 165.85%
15,951 $80,000
Q2 2020

Aug 14, 2020

BUY
$7.25 - $11.75 $38,425 - $62,275
5,300 Added 757.14%
6,000 $48,000
Q1 2020

May 18, 2020

BUY
$4.06 - $10.64 $2,841 - $7,448
700 New
700 $6,000

Others Institutions Holding AVDL

About AVADEL PHARMACEUTICALS PLC


  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $626M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.